Model 4 - treated | Model 5 - treated (with mastectomy) | |||||||
---|---|---|---|---|---|---|---|---|
Subhazard Risk Ratio | 95% CIs | z | p > |z| | Subhazard Risk Ratio | 95% CIs | z | p > |z| | |
Aboriginal | ||||||||
No | ||||||||
Yes | ||||||||
Stage at diagnosis | ||||||||
Local | 1.00 | Reference | 1.00 | Reference | ||||
Regional | 34.23 | 6.76–173.40 | 4.27 | 0.000 | 48.81 | 3.63–655.42 | 2.93 | 0.003 |
Distant or Unknown | 49.67 | 6.79–363.51 | 3.85 | 0.000 | 69.21 | 4.21–1138.25 | 2.97 | 0.003 |
Listed with BSSA | ||||||||
No | ||||||||
Yes | ||||||||
Screened by BSSA | ||||||||
No | 1.00 | Reference | 1.00 | Reference | ||||
Yes | 0.07 | 0.01–0.83 | −2.11 | 0.035 | 0.05 | 0.01–0.40 | −2.78 | 0.005 |
Systemic therapy | ||||||||
No | 1.00 | Reference | 1.00 | Reference | ||||
Yes | 0.06 | 0.01–0.41 | −2.88 | 0.004 | 0.05 | 0.01–0.21 | −4.11 | 0.000 |
Surgical treatment | ||||||||
No | 1.00 | Reference | ||||||
Yes | 0.17 | 0.04–0.74 | −2.36 | 0.018 | ||||
Mastectomy | ||||||||
No mastectomy | 1.00 | Reference | ||||||
Partial | 0.10 | 0.01–0.88 | −2.08 | 0.038 | ||||
Simple/ subcutaneous | 0.23 | 0.06–0.86 | −2.19 | 0.029 | ||||
AIC | 28.9 | 28.9 |